Caroline Happold

1.8k total citations
25 papers, 1.1k citations indexed

About

Caroline Happold is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, Caroline Happold has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 12 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Caroline Happold's work include Glioma Diagnosis and Treatment (16 papers), Brain Metastases and Treatment (5 papers) and Histone Deacetylase Inhibitors Research (5 papers). Caroline Happold is often cited by papers focused on Glioma Diagnosis and Treatment (16 papers), Brain Metastases and Treatment (5 papers) and Histone Deacetylase Inhibitors Research (5 papers). Caroline Happold collaborates with scholars based in Germany, Switzerland and United States. Caroline Happold's co-authors include Michael Weller, Patrick Roth, Alexandra Kretz, Stefan Isenmann, Wolfgang Wick, Guido Reifenberger, Manuela Silginer, Günter Eisele, Ana‐Maria Florea and Silvia Höfer and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Nature Protocols.

In The Last Decade

Caroline Happold

25 papers receiving 1.1k citations

Peers

Countries citing papers authored by Caroline Happold

Since Specialization

Citations

This map shows the geographic impact of Caroline Happold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline Happold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline Happold more than expected).

Fields of papers citing papers by Caroline Happold

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline Happold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline Happold. The network helps show where Caroline Happold may publish in the future.

Co-authorship network of co-authors of Caroline Happold

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline Happold. A scholar is included among the top collaborators of Caroline Happold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline Happold. Caroline Happold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Do statins, ACE inhibitors or sartans improve outcome in primary glioblastoma? 2018 ·Journal of Neuro-Oncology ·Caroline Happold, Thierry Gorlia, Burt Nabors, Sara Erridge, David A. Reardon, Christine Hicking, Martin Picard, Roger Stupp, Michael Weller	30
2	Transcriptional control of O⁶‐methylguanine DNA methyltransferase expression and temozolomide resistance in glioblastoma 2018 ·Journal of Neurochemistry ·Caroline Happold, (unknown), Manuela Silginer, Tobias Weiß, Patrick Roth, Guido Reifenberger, Michael Weller	25
3	Autocrine activation of the IFN signaling pathway may promote immune escape in glioblastoma 2017 ·Neuro-Oncology ·Manuela Silginer, (unknown), Caroline Happold, Hannah Schneider, Michael Weller, Patrick Roth	48
4	MicroRNA-138 promotes acquired alkylator resistance in glioblastoma by targeting the Bcl-2-interacting mediator BIM 2016 ·Oncotarget ·(unknown), (unknown), Steffen Sass, Patrick Roth, Ana‐Maria Florea, Anja Stefanski, Kai Stühler, Marietta Wolter, Nikola S. Müller, Fabian J. Theis, Michael Weller, Guido Reifenberger, Caroline Happold	51
5	Interferon-β Modulates the Innate Immune Response against Glioblastoma Initiating Cells 2015 ·PLoS ONE ·Fabian Wolpert, Caroline Happold, Guido Reifenberger, Ana‐Maria Florea, René Deenen, Patrick Roth, Marian C. Neidert, Katrin Lamszus, Manfred Westphal, Michael Weller, Günter Eisele	10
6	Management of diffusely infiltrating glioma in the elderly 2015 ·Current Opinion in Oncology ·Hans‐Georg Wirsching, Caroline Happold, Patrick Roth, Michael Weller	5
7	Interferon-β Induces Loss of Spherogenicity and Overcomes Therapy Resistance of Glioblastoma Stem Cells 2014 ·Molecular Cancer Therapeutics ·Caroline Happold, Patrick Roth, Manuela Silginer, Ana‐Maria Florea, Katrin Lamszus, Karl Frei, René Deenen, Guido Reifenberger, Michael Weller	43
8	Corticosteroid use in neuro-oncology: an update 2014 ·Neuro-Oncology Practice ·Patrick Roth, Caroline Happold, Michael Weller	51
9	Glioma Cell Death Induced by Irradiation or Alkylating Agent Chemotherapy Is Independent of the Intrinsic Ceramide Pathway 2013 ·PLoS ONE ·Dorothee Gramatzki, (unknown), Caroline Happold, Katrin Anne Becker, Erich Gulbins, Michael Weller, Ghazaleh Tabatabai	16
10	Bevacizumab Alone or in Combination with Irinotecan in Recurrent WHO Grade II and Grade III Gliomas 2012 ·European Neurology ·Katharina Seystahl, Benedikt Wiestler, Thomas Hundsberger, Caroline Happold, Wolfgang Wick, Michael Weller, Antje Wick	19
11	Distinct molecular mechanisms of acquired resistance to temozolomide in glioblastoma cells 2012 ·Journal of Neurochemistry ·Caroline Happold, Patrick Roth, Wolfgang Wick, (unknown), Ana‐Maria Florea, Manuela Silginer, Guido Reifenberger, Michael Weller	118
12	Antiangiogenic Treatment for Multiple CNS Hemangioblastomas 2012 ·Onkologie ·(unknown), Katharina Seystahl, Silvia Höfer, Caroline Happold, (unknown), Michael Weller	15
13	A specific miRNA signature in the peripheral blood of glioblastoma patients 2011 ·Journal of Neurochemistry ·Patrick Roth, Jörg Wischhusen, Caroline Happold, P. Anoop Chandran, Silvia Höfer, Günter Eisele, Michael Weller, Andreas Keller	172
14	Long-Term Survival of Patients With Glioblastoma Treated With Radiotherapy and Lomustine Plus Temozolomide 2009 ·Journal of Clinical Oncology ·Martin Glas, Caroline Happold, Johannes Rieger, Dorothee Wiewrodt, Oliver Bähr, Joachim P. Steinbach, Wolfgang Wick, Rolf‐Dieter Kortmann, Guido Reifenberger, Michael Weller, Ulrich Herrlinger	99
15	ACNU-based chemotherapy for recurrent glioma in the temozolomide era 2008 ·Journal of Neuro-Oncology ·Caroline Happold, Patrick Roth, Wolfgang Wick, Joachim P. Steinbach, Michael Linnebank, Michael Weller, Günter Eisele	32
16	Anticoagulation for radiation-induced neurotoxicity revisited 2008 ·Journal of Neuro-Oncology ·Caroline Happold, Ulrike Ernemann, Patrick Roth, Wolfgang Wick, Michael Weller, Friederike Schmidt	18
17	A series of patients with subpial hemorrhage: Clinical manifestation, neuroradiological presentation and therapeutic implications 2008 ·Journal of Neurology ·Patrick Roth, Caroline Happold, Günter Eisele, (unknown), Michael Weller, Andreas R. Luft	16
18	A primary culture technique of adult retina for regeneration studies on adult CNS neurons 2007 ·Nature Protocols ·Alexandra Kretz, (unknown), Caroline Happold, Christian Schmeer, Stefan Isenmann	17
19	Erythropoietin promotes regeneration of adult CNS neurons via Jak2/Stat3 and PI3K/AKT pathway activation 2005 ·Molecular and Cellular Neuroscience ·Alexandra Kretz, Caroline Happold, (unknown), Stefan Isenmann	157
20	Excess Bcl-XL increases the intrinsic growth potential of adult CNS neurons in vitro 2004 ·Molecular and Cellular Neuroscience ·Alexandra Kretz, Sebastian Kügler, Caroline Happold, Mathias Bähr, Stefan Isenmann	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact